Format

Send to

Choose Destination
Acta Psychiatr Scand. 2016 Apr;133(4):298-309. doi: 10.1111/acps.12530. Epub 2015 Nov 21.

Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in-patient settings.

Author information

1
School of Psychology, University of Birmingham, Edgbaston, Birmingham, UK.
2
School of Psychology, University of Bath, Claverton Down, Bath, UK.
3
Department of Primary Care and Population Health, Upper Third Floor, UCL Medical School (Royal Free Campus), London, UK.
4
Health Service and Population Research Department, Institute of Psychiatry, Kings College London, London, UK.
5
Division of Mental Health and Wellbeing, University of Warwick, Coventry, UK.

Abstract

OBJECTIVE:

This proof of principle study evaluated the effectiveness and feasibility of a brief motivational intervention, delivered in mental health in-patient settings, to improve engagement in treatment for drug and alcohol misuse.

METHOD:

A randomised controlled trial using concealed randomisation, blind, independent assessment of outcome at 3 months. Participants were 59 new adult admissions, to six acute mental health hospital units in one UK mental health service, with schizophrenia related or bipolar disorder diagnoses, users of community mental health services and also misusing alcohol and/or drugs. Participants were randomised to Brief Integrated Motivational Intervention (BIMI) with Treatment As Usual (TAU), or TAU alone. The BIMI took place over a 2-week period and encouraged participants to explore substance use and its impact on mental health.

RESULTS:

Fifty-nine in-patients (BIMI n = 30; TAU n = 29) were randomised, the BIMI was associated with a 63% relative odds increase in the primary outcome engagement in treatment [OR 1.63 (95% CI 1.01-2.65; P = 0.047)], at 3 months. Qualitative interviews with staff and participants indicated that the BIMI was both feasible and acceptable.

CONCLUSION:

Mental health hospital admissions present an opportunity for brief motivational interventions focussed on substance misuse and can lead to improvements in engagement.

KEYWORDS:

dual diagnosis; hospital admission; randomised controlled trial; schizophrenia; substance misuse

PMID:
26590876
PMCID:
PMC5091625
DOI:
10.1111/acps.12530
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center